Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.16324
Abstract: H., Uusimaa, J., Moilanen, J., Tedg ard, U., Cammenga, J. & Bryceson, Y.T. (2017) Gain-offunction SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. Blood, 129, 2266–2279. Wong, J.C., Bryant, V., Lamprecht,… read more here.
Keywords: therapy relapsed; multicentre experience; carfilzomib therapy; myeloma results ... See more keywords